FAMEDS founder condemns FDA decision on Avastin for metastatic breast cancer
 

Breast cancer patients, their families and advocates expressed extreme disappointment at today's Food and Drug Administration (FDA) decision to remove the anti-cancer drug Avastin from the approved medication list for treatment of late stage breast cancer.

More...